Free Trial

Brainsway (BWAY) Competitors

Brainsway logo
$15.26 -0.64 (-4.03%)
Closing price 08/27/2025 04:00 PM Eastern
Extended Trading
$15.40 +0.14 (+0.92%)
As of 04:05 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

BWAY vs. INMD, IRMD, KMTS, EMBC, BBNX, TNDM, AXGN, SIBN, BVS, and ZIMV

Should you be buying Brainsway stock or one of its competitors? The main competitors of Brainsway include InMode (INMD), iRadimed (IRMD), Kestra Medical Technologies (KMTS), Embecta (EMBC), Beta Bionics (BBNX), Tandem Diabetes Care (TNDM), AxoGen (AXGN), SiBone (SIBN), Bioventus (BVS), and ZimVie (ZIMV). These companies are all part of the "medical equipment" industry.

Brainsway vs. Its Competitors

InMode (NASDAQ:INMD) and Brainsway (NASDAQ:BWAY) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, profitability, analyst recommendations, dividends, media sentiment, risk, valuation and institutional ownership.

InMode has higher revenue and earnings than Brainsway. InMode is trading at a lower price-to-earnings ratio than Brainsway, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
InMode$394.82M2.43$181.27M$2.476.15
Brainsway$41.02M7.03$2.92M$0.2658.69

InMode has a beta of 1.93, indicating that its stock price is 93% more volatile than the S&P 500. Comparatively, Brainsway has a beta of 1.42, indicating that its stock price is 42% more volatile than the S&P 500.

InMode currently has a consensus target price of $18.04, indicating a potential upside of 18.77%. Brainsway has a consensus target price of $18.00, indicating a potential upside of 17.96%. Given InMode's higher probable upside, equities analysts clearly believe InMode is more favorable than Brainsway.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
InMode
0 Sell rating(s)
7 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.13
Brainsway
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00

InMode has a net margin of 44.50% compared to Brainsway's net margin of 11.60%. InMode's return on equity of 18.38% beat Brainsway's return on equity.

Company Net Margins Return on Equity Return on Assets
InMode44.50% 18.38% 16.35%
Brainsway 11.60%8.97%5.65%

In the previous week, InMode and InMode both had 8 articles in the media. InMode's average media sentiment score of 1.76 beat Brainsway's score of 0.30 indicating that InMode is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
InMode
7 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive
Brainsway
0 Very Positive mention(s)
2 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

68.0% of InMode shares are owned by institutional investors. Comparatively, 30.1% of Brainsway shares are owned by institutional investors. 6.9% of InMode shares are owned by insiders. Comparatively, 19.0% of Brainsway shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Summary

InMode beats Brainsway on 10 of the 15 factors compared between the two stocks.

Get Brainsway News Delivered to You Automatically

Sign up to receive the latest news and ratings for BWAY and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BWAY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BWAY vs. The Competition

MetricBrainswayMED PRODUCTS IndustryMedical SectorNASDAQ Exchange
Market Cap$300.54M$10.72B$5.76B$9.78B
Dividend YieldN/A1.86%3.95%4.03%
P/E Ratio58.6921.2030.8526.37
Price / Sales7.0331.81471.21121.78
Price / Cash63.7624.9437.7659.36
Price / Book4.243.5010.136.62
Net Income$2.92M$210.11M$3.26B$265.42M
7 Day Performance1.80%4.70%2.86%3.15%
1 Month Performance27.17%11.78%4.02%0.82%
1 Year Performance93.16%-6.50%43.37%22.99%

Brainsway Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BWAY
Brainsway
3.0301 of 5 stars
$15.26
-4.0%
$18.00
+18.0%
+89.8%$300.54M$41.02M58.69120Analyst Forecast
INMD
InMode
2.4156 of 5 stars
$14.31
-0.3%
$18.04
+26.1%
-2.8%$907.05M$394.82M5.79480Positive News
IRMD
iRadimed
4.5974 of 5 stars
$70.11
-0.4%
$72.00
+2.7%
+59.1%$895.23M$73.24M43.28110Positive News
KMTS
Kestra Medical Technologies
1.2738 of 5 stars
$16.09
+0.2%
$27.33
+69.9%
N/A$824.15M$59.81M0.00300News Coverage
Positive News
Lockup Expiration
EMBC
Embecta
4.7118 of 5 stars
$13.48
-1.5%
$19.00
+40.9%
-0.1%$800.66M$1.12B9.432,100Positive News
BBNX
Beta Bionics
1.5562 of 5 stars
$17.26
+1.3%
$22.56
+30.7%
N/A$740.73M$65.12M0.00294
TNDM
Tandem Diabetes Care
4.6398 of 5 stars
$10.84
+0.2%
$22.67
+109.1%
-73.1%$731.10M$940.20M-3.512,650
AXGN
AxoGen
2.6191 of 5 stars
$15.49
+3.8%
$26.00
+67.9%
+27.0%$686.97M$203.27M-154.88450News Coverage
SIBN
SiBone
4.2639 of 5 stars
$15.54
+0.5%
$23.67
+52.3%
+0.7%$666.96M$167.18M-27.75350News Coverage
Positive News
BVS
Bioventus
0.8962 of 5 stars
$7.18
-2.6%
N/AN/A$609.34M$573.28M14.741,200
ZIMV
ZimVie
0.5058 of 5 stars
$18.95
+0.5%
$17.75
-6.3%
+9.1%$531.59M$449.75M-27.071,770

Related Companies and Tools


This page (NASDAQ:BWAY) was last updated on 8/28/2025 by MarketBeat.com Staff
From Our Partners